Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients-Reference-Cited by-同舟云学术

Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients

Published:2013-03 Issue:3 Volume:45 Page:245-250
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Aparicio Thomas,Schischmanoff Olivier,Poupardin Cecile,Soufir Nadem,Angelakov Celine,Barrat Christophe,Levy Vincent,Choudat Laurence,Cucherousset Joel,Boubaya Marouane,Lagorce Christine,Des Guetz Gaetan,Wind Philippe,Benamouzig Robert

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators;Lancet,1995

2. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma;Moertel;New England Journal of Medicine,1990

3. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;New England Journal of Medicine,2004

4. Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT Database;McCleary;Journal of Clinical Oncology,2009

5. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients;Sargent;New England Journal of Medicine,2001

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials;Journal of Clinical Oncology;2024-07-01

2. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC;Frontiers in Surgery;2024-06-14

3. Lymphatic spread patterns in young versus elderly patients with stage III colon cancer;BJS Open;2024-05-08

4. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR);Digestive and Liver Disease;2024-05

5. Aging and cancer: Clinical role of tumor markers in the geriatric population (Review);Medicine International;2024-03-06